Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Pubertal Blockade and Hormone Therapy on Cardiometabolic Risk Markers in Transgender Adolescents

NCT03557268 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03557268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03557268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Pubertal Blockade and Hormone Therapy on Cardiometabolic Risk Markers in Transgender Adolescents
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Completed
Start date
June 19, 2018
Completion date
September 9, 2020
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gender dysphoria, gender identity, gender identity disorder in adolescence and adulthood